Cabaletta Bio Announces 2027 Rese-Cel BLA Submission Anticipated In Myositis Following Recent FDA Alignment On Registrational Cohorts
ReutersMay 15, 2025 11:34 AM
May 15 (Reuters) - Cabaletta Bio Inc CABA.O:
CABALETTA BIO ANNOUNCES 2027 RESE-CEL BLA SUBMISSION ANTICIPATED IN MYOSITIS FOLLOWING RECENT FDA ALIGNMENT ON REGISTRATIONAL COHORTS
CABALETTA BIO INC: SLE AND LN REGISTRATIONAL DISCUSSIONS WITH FDA ANTICIPATED IN 3Q25
CABALETTA BIO INC: SYSTEMIC SCLEROSIS REGISTRATIONAL DISCUSSIONS WITH FDA ANTICIPATED IN 4Q25
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Japan's economy has fallen back to negative growth after one year. Will yen continue to weaken?
TradingKey - Japan's economic performance is lackluster, with the preliminary annualized quarterly GDP for the first quarter recorded at -0.7%. This marks the first contraction in a year, and the economy may face further impacts from Trump’s tariffs.TradingKey
3 hours ago
Asset Tokenization Explained: Why Are Wall Street Giants Rushing In and How Can Retail Investors Grab A Bite?
Asset tokenization refers to the process of converting stocks, bonds, real estate, collectibles, private equity, and other assets into digital tokens on the blockchain. Each token represents fractional ownership or rights to an asset and can be traded on digital platforms.TradingKey
3 hours ago
What Are the Key U.S. Inflation Indicators? How Does CPI Affect the PCE Index?
TradingKey - When discussing U.S. inflation, the CPI (Consumer Price Index) and PCE (Personal Consumption Expenditures Price Index) are considered the two most important indicators for measuring consumer inflation. The earlier release of CPI can influence PCE through price linkages, changes in...TradingKey
5 hours ago
Tesla Q1 2025 Earning Report Review: Autonomous Driving and Robotics Lead Future Growth
TradingKey - Tesla's Q1 2025 earnings results revealed short-term financial pressure, with core data lower than market expectations, and both revenue and profitability facing challenges. Against the backdrop of sales and profit pressure, Musk remains confident in Tesla's future.TradingKey
Wed, Apr 23
US Stock Market’s 2025 Outlook: Navigating the Shifting Landscape
TradingKey - Anyone who has invested in US stocks in 2024 will be happy. The US stock market has delivered an absolutely blockbuster performance so far this year, with the S&P 500 Index soaring 26.9% year-to-date (as of December 16), reaching record highs.TradingKey
Mon, Dec 30
